Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Borderline and Locally Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06944587
What this trial is testing

A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerBorderline Resectable Pancreatic CancerPancreatectomy+1 more
Oslo University Hospital 400
Testing effectiveness (Phase 2)UnknownNCT04289792
What this trial is testing

Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Fujian Medical University Union Hospital 27
Testing effectiveness (Phase 2)Ended earlyNCT01760252
What this trial is testing

Neoadjuvant CAPOXIRI Chemotherapy in the Treatment of Pancreatic Adenocarcinoma Protocol

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Beth Israel Medical Center 17
Not applicableLooking for participantsNCT05298722
What this trial is testing

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial)

Who this might be right for
Pancreatic Cancer
University Hospital, Ghent 45
Not applicableStudy completedNCT05888129
What this trial is testing

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Postoperative Complications
Asan Medical Center 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT04539808
What this trial is testing

NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaStage 0 Pancreatic Cancer American Joint Committee on Cancer v8Stage I Pancreatic Cancer American Joint Committee on Cancer v8+2 more
OHSU Knight Cancer Institute
Early research (Phase 1)Not Yet RecruitingNCT06346808
What this trial is testing

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Who this might be right for
Pancreatic Cancer
Sichuan University 20
Testing effectiveness (Phase 2)Study completedNCT05908747
What this trial is testing

Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 29
Not applicableUnknownNCT05470738
What this trial is testing

PAncreas Borderline and Locally Advanced Snapshot Study

Who this might be right for
Pancreatic Cancer
University Hospital, Clermont-Ferrand 230
Large-scale testing (Phase 3)UnknownNCT04617821
What this trial is testing

AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
Fudan University 300
Early research (Phase 1)Study completedNCT02394535
What this trial is testing

Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic AdenocarcinomaPancreatic Adenocarcinoma+4 more
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07208539
What this trial is testing

AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Shanghai Zhongshan Hospital 77
Testing effectiveness (Phase 2)Study completedNCT04247165
What this trial is testing

Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.

Who this might be right for
Borderline Resectable, Locally Advanced or Metastatic Pancreatic Cancer
Herlev Hospital 55
Not applicableLooking for participantsNCT05356039
What this trial is testing

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreas CancerPancreas NeoplasmPancreas Disease+6 more
Umeå University 300
Testing effectiveness (Phase 2)Study completedNCT03983057
What this trial is testing

Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Zhejiang University 392
Early research (Phase 1)Active Not RecruitingNCT02207465
What this trial is testing

A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer

Who this might be right for
Locally Advanced Unresectable Pancreatic Cancer Treated With ChemoradiotherapyBorderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy
Abramson Cancer Center at Penn Medicine 42
Testing effectiveness (Phase 2)UnknownNCT01676259
What this trial is testing

SiG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Silenseed Ltd 80
Not applicableLooking for participantsNCT06574620
What this trial is testing

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Who this might be right for
Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic Ductal Adenocarcinoma+1 more
British Columbia Cancer Agency 200
Testing effectiveness (Phase 2)Looking for participantsNCT02843945
What this trial is testing

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Who this might be right for
Pancreatic Cancer
CivaTech Oncology 80
Early research (Phase 1)Study completedNCT01903083
What this trial is testing

Chemoimmunotherapy and Radiation in Pancreatic Cancer

Who this might be right for
Locally Advanced Malignant Neoplasm
Providence Health & Services 10
Next Page
42